º£½ÇÊÓƵ

Load mobile navigation

Pharmaceuticals

GSK lifts sales targets as HIV and oncology drugs boost growth
Pharmaceuticals
Shares in the company rose on Wednesday morning as a result, lifting to their highest level for 18 months
Bookmark
Shield Therapeutics signals strong momentum as iron deficiency drug sales ramp up
Pharmaceuticals
Bosses say the firm is on track to become cash flow positive by the end of 2025.
Bookmark
York's Aptamer Group secures work with 'top three' global pharma customer
Pharmaceuticals
Its latest contract is to develop binders for use in the multibillion dollar radiopharmaceuticals market.
Bookmark
Eli Lilly's º£½ÇÊÓƵ turnover almost doubles after Mounjaro sale
By City AM
The º£½ÇÊÓƵ arm of US pharmaceuticals giant Eli Lilly has posted a turnover of £889m for 2024, according to new accounts filed with Companies House
Bookmark
GSK to invest $30bn in US over next five years in fresh blow to º£½ÇÊÓƵ's pharma sector
By City AM
The London-based business said the capital would be deployed over the next five years and would create hundreds of high-skilled American jobs in areas such as AI and advanced digital technologies
Bookmark
Merck scraps £1bn London research centre and axes 127 jobs in fresh blow to º£½ÇÊÓƵ
By City AM
The US pharma giant is to lay off 127 staff alongside abandoning the construction project, which had been set to open in King's Cross in 2027. The firm warned the º£½ÇÊÓƵ would lag behind the rest of Europe for spending on health research unless it made conditions more attractive to invest.
Bookmark
Revenues rise and losses narrow as Shield Therapeutics as US sales deliver major boost
Pharmaceuticals
The Gateshead pharma firm has been involved in a significant push of its iron deficiency-fighting tablets in the States
Bookmark
Pair of pharmacies sold to enable retirement
West Midlands
Sites have been bought by growing family-run business
Bookmark
Newcastle life sciences agency ramarketing opens new headquarters as it marks 16 years in business
property news
The company has expanded for the fourth time in Newcastle into The Catalyst
Bookmark
Astrazeneca sees demand for cancer drugs soar as it mulls US listing
By City AM
Total revenue rose 11 per cent to $28bn (£12.98bn) in the first half of the year, driven by double-digit growth in Oncology and BioPharmaceuticals, the pharmaceutical giant told markets this morning
Bookmark
GSK insists it's 'well positioned' as Trump's pharma tariffs loom
By City AM
The FTSE 100 drugmaker said it was "well positioned" to tackle the impact of sector-specific tariffs as speculation mounts that President Donald Trump is preparing to target pharmaceutical imports
Bookmark
Newcastle tech firm QuantuMDx narrows losses amid upgrade to pioneering health device
Technology
The firm's Q-POC device aims to provide diagnoses for a range of illnesses within minutes
Bookmark
Pharma firm Shield Therapeutics warns of 'unpredictability' from US tariffs
Company Results
The commercial stage business has significantly boosted prescriptions and narrowed losses
Bookmark
Astrazeneca CEO blasts Europe for 'putting health of its people at risk'
By City AM
CEO Pascal Soriot said Europe was "falling behind" in attracting investment and needed to "invest more in what really matters to it"
Bookmark
Shield Therapeutics signs licence deal with Vital-Net to break into Japan
Deals
The Gateshead pharmaceutical firm has received an initial payment of $665,000 as part of the exclusive licence agreement
Bookmark
Biotech business Atelerix signs distribution deal to expand into China
Deals
The firm has signed an exclusive distribution agreement with MineBio, a leading Chinese supply chain and logistics organisation
Bookmark
Aelius Biotech scientists raise £750,000 to expand overseas presence
Deals
Aelius’s model is the only one of its type that can simulate all three stages of the digestion process – from substances passing through the gut, crossing the mucus layer on its surface and being absorbed into the body.
Bookmark
Newcastle recruitment company Lead Candidate launches own drive for new employees
Pharmaceuticals
The specialist recruitment firm has also moved into a brand new Newcastle city centre head office at 8 Nelson Street
Bookmark
FTSE 100 pharma giants GSK and Astrazeneca may have dodged Trump tariffs
By City AM
Pharmaceutical goods appear to be exempt from higher-rate tariffs introduced by President Trump in his 'Liberation Day' address on Wednesday, according to a City broker
Bookmark
Aptamer Group doubles half-year revenue as firm sees 'strong and sustainable' commercial momentum
Company Results
The Yorl business said it is now signing multiple new contracts with global market-leading pharmaceutical companies
Bookmark
Northumberland life sciences firm seals £500k investment to fund trials for cancer-prevention treatment
Deals
The Alnwick business is poised to draw up a clinical trial for HELIX, the firm's first product being brought to market
Bookmark
Hikma Pharmaceuticals' revenue grows nine per cent to £2.47bn as profit booms
By City AM
The pharmaceutical company said the bulk of its growth came from its North American arm as well as recent product launches
Bookmark
North East life sciences experiencing a wave of optimism - but there are challenges to overcome
Chamber of Commerce
The first of what is hoped to be an annual study of the region's sector is positive but lack of funding, laboratory space and big changes with the US trading relationship pose difficulties for firms
Bookmark
Astrazeneca says it's 'too big' to base CEO's pay packet on FTSE 100 peers
By City AM
Astrazeneca has defended the £14.7 million pay package handed to chief executive Pascal Soriot, saying the group is too big and complex to base his remuneration on the rest of the FTSE 100 index
Bookmark
Story Saved
You can find this story in  My Bookmarks.Or by navigating to the user icon in the top right.